Adverse antiepileptic drug effects in new-onset seizures: a case-control study.
OBJECTIVE
Adverse effects (AEs) are a major concern when starting antiepileptic drug (AED) treatment. This study quantified the extent to which AE reporting in people with new-onset seizures started on AEDs is attributable to the medication per se, and investigated variables contributing to AE reporting.


METHODS
We pooled data from 2 large prospective studies, the Multicenter Study of Early Epilepsy and Single Seizures and the Northern Manhattan Study of incident unprovoked seizures, and compared adverse event profile (AEP) total and factor scores between adult cases prescribed AEDs for new-onset seizures and untreated controls, adjusting for several demographic and clinical variables. Differences in AEP scores were also tested across different AED monotherapies and controls, and between cases and controls grouped by number of seizures.


RESULTS
A total of 212 cases and 206 controls were identified. Most cases (94.2%) were taking low AED doses. AEP scores did not differ significantly between the 2 groups. Depression, female gender, symptomatic etiology, younger seizure onset age, ≥2 seizures, and history of febrile seizures were associated with higher AEP scores. There were no significant differences in AEP scores across different monotherapies and controls. AEP scores increased in both cases and controls with increasing number of seizures, the increment being more pronounced in cases.


CONCLUSIONS
When AED treatment is started at low doses following new-onset seizures, AE reporting does not differ from untreated individuals. Targeting specific factors affecting AE reporting could lead to improved tolerability of epilepsy treatment.
Institute of Neurology IRCCS C. Mondino Foundation, University of Pavia, Pavia, Italy. piero.perucca@libero.it
P
P
Perucca
A
A
Jacoby
A G
AG
Marson
G A
GA
Baker
S
S
Lane
E K T
EK
Benn
D J
DJ
Thurman
W A
WA
Hauser
F G
FG
Gilliam
D C
DC
Hesdorffer
D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects*; D016022:Case-Control Studies; D003071:Cognition / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009048:Motor Skills / Q000187:drug effects; D015337:Multicenter Studies as Topic; D011446:Prospective Studies; D012640:Seizures / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology*; D012890:Sleep / Q000187:drug effects; D055815:Young Adult
D000927:Anticonvulsants
Epilepsia. 2008 Aug;49(8):1431-9
18336560
Ann Neurol. 2006 Jul;60(1):80-7
16802302
Neurology. 2009 Apr 7;72(14):1223-9
19349601
Neurology. 2004 Jan 27;62(2):258-61
14745064
N Engl J Med. 1995 Dec 14;333(24):1600-7
7477195
CNS Drugs. 2008;22(11):917-38
18840033
Neurology. 2007 Apr 10;68(15):1188-96
17420402
Epilepsia. 2007 Jul;48(7):1223-44
17386054
Epilepsia. 2000 Sep;41(9):1119-28
10999551
Epilepsia. 1998 Feb;39(2):213-31
9578003
Curr Opin Neurol. 2009 Apr;22(2):167-73
19532041
Neurology. 2004 Nov 23;63(10 Suppl 4):S9-S12
15557551
Clin Pharmacol Ther. 2007 Jul;82(1):87-96
17495875
N Engl J Med. 2000 Feb 3;342(5):314-9
10660394
Lancet. 2005 Jun 11-17;365(9476):2007-13
15950714
Neurology. 2004 Jan 13;62(1):23-7
14718691
Ann Neurol. 2006 Jan;59(1):35-41
16217743
Neurology. 2004 Sep 28;63(6):1008-14
15452291
Epilepsia. 1993 Jul-Aug;34(4):592-6
8330566
J Am Acad Child Adolesc Psychiatry. 2000 Jan;39(1):28-38
10638065
Epilepsia. 2008 Mar;49(3):500-8
18028407
Biol Psychiatry. 2003 Aug 1;54(3):388-98
12893113
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
6880820
Epilepsia. 1997 Mar;38(3):353-62
9070599
Neurology. 2009 May 19;72(20):1747-54
19246420
Lancet Neurol. 2006 May;5(5):399-405
16632310
Epilepsia. 2007 Mar;48(3):456-63
17284301
Epilepsia. 2001 Oct;42(10):1255-60
11737159
Neurology. 2003 Jun 10;60(11 Suppl 4):S26-30
12796518
Neurology. 1999 Jul 13;53(1):162-6
10408553
Br J Gen Pract. 1999 Mar;49(440):211-4
10343425
Br J Gen Pract. 2007 Oct;57(543):801-7
17925137
Lancet. 1996 Jun 15;347(9016):1651-3
8642958